Discontinued — last reported Q3 '22
Elevance Health IngenioRx Segment — Insurance Services Revenue increased by 11.4% to $3.97B in Q3 2022 compared to the prior quarter. Year-over-year, this metric grew by 17.9%, from $3.37B to $3.97B. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growth in member enrollment, higher drug utilization, or successful expansion of pharmacy services to new clients.
This represents the total revenue generated from pharmacy benefit management services provided to health plan members an...
Directly comparable to PBM revenue streams at other major health insurers or standalone pharmacy benefit managers.
elv_segment_ingeniorx_segment_insurance_services_revenue| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | |
|---|---|---|---|---|---|
| Value | $3.04B | $3.37B | $3.30B | $3.57B | $3.97B |
| QoQ Change | — | +10.7% | -2.0% | +8.0% | +11.4% |
| YoY Change | — | — | — | +17.2% | +17.9% |